The WHO has announced it is suspending a trial of hydroxychloroquine in coronavirus patients over safety concerns. US President Donald Trump announced he had been taking the anti-malaria drug earlier this month, and yesterday confirmed he had finished a two-week course.
A study published in The Lancet on Friday revealed higher mortality rates among Covid-19 patients who had taken the drug. Researchers have now paused its use in the WHO’s worldwide Solidarity trial.
This is a breaking news story and is constantly being updated. Please refresh the page regularly to get the latest updates. Reporters working on dailystar.co.uk will be working to source the latest information, reaction, pictures and video related to this story.